Drag a card by its title · ⚙ to size, swap or remove

The company

Assembly Biosciences, Inc.

ASMB · Nasdaq

Health CareBiotechnologyNot moving yet

ASMB stood above a rising 150-day average in 18 of the last 52 weekly readings, and has been out of that trend for the last 5 weeks. It is 26.8% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 5
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $29K
Officials’ trades on record: 2
Institutions holding: 90 (+19)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 18 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

2 disclosed lines: House 2, Senate 0, executive 0; 1 people.

Who	Did	Amount	Traded
Chris Jacobs House: U.S. House ClerkNY27	sold	$1k–$15k	4 Jan 2021filed 17 Feb 2021
Chris Jacobs House: U.S. House ClerkNY27	bought	$1k–$15k	28 Dec 2020filed 10 Feb 2021

Insiders

Buy orders, 12 months0

Sale orders, 12 months3

Buyers · sellers0 · 2

Who	Did	Shares	Traded
Jeanette M. BjorkquistPFO and PAO	sold	29at $23.25	17 Jun 2026filed 18 Jun 2026
Nicole S. WhiteChief Manufacturing Officer	sold	188at $26.65	30 Mar 2026filed 31 Mar 2026
Nicole S. WhiteChief Manufacturing Officer	sold	9at $27.49	30 Mar 2026filed 31 Mar 2026
Jeanette M. BjorkquistPFO and PAO	sold	312at $26.65	30 Mar 2026filed 31 Mar 2026
Jeanette M. BjorkquistPFO and PAO	sold	16at $27.49	30 Mar 2026filed 31 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders90+19 on the quarter

New · exited34 · 16

Reported value$514.2M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
GILEAD SCIENCES, INC.added · filed 3 Aug 2026	4,977,089$136.8M	+471,698+10.5%
FARALLON CAPITAL MANAGEMENT, L.L.C.added · filed 14 Aug 2026	1,604,590$44.1M	+377,000+30.7%
Paradigm Biocapital Advisors LPadded · filed 14 Aug 2026	1,553,748$42.7M	+888,497+133.6%
Commodore Capital LPadded · filed 14 Aug 2026	1,415,000$38.9M	+415,000+41.5%
RA CAPITAL MANAGEMENT, L.P.unchanged · filed 14 Aug 2026	1,020,410$28.0M	00.0%
Jupiter Topco LLCnew · filed 14 Aug 2026	849,309$23.4M	+849,309
BlackRock, Inc.added · filed 7 Aug 2026	766,819$21.1M	+564,076+278.2%
Parkman Healthcare Partners LLCadded · filed 14 Aug 2026	721,181$19.8M	+309,954+75.4%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	558,942$15.4M	+68,495+14.0%
Point72 Asset Management, L.P.added · filed 14 Aug 2026	460,593$12.7M	+116,488+33.9%